IE782146L - Immunologically active prp. - Google Patents

Immunologically active prp.

Info

Publication number
IE782146L
IE782146L IE782146A IE214678A IE782146L IE 782146 L IE782146 L IE 782146L IE 782146 A IE782146 A IE 782146A IE 214678 A IE214678 A IE 214678A IE 782146 L IE782146 L IE 782146L
Authority
IE
Ireland
Prior art keywords
prp
immunologically active
antibody
obtainable
purification
Prior art date
Application number
IE782146A
Other versions
IE47474B1 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IE782146L publication Critical patent/IE782146L/en
Publication of IE47474B1 publication Critical patent/IE47474B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides methods for the purification of polyribosyl ribitol phosphate (PRP) from Haemophilus influenzae type b cultures, as well as novel forms of immunologically active PRP obtainable by such methods and combined vaccines containing immunologically active PRP and Bordetella pertussis antigens. The purification methods involve removing contaminants to a low level by treating the PRP in the form of a hexadecyltrimethyl ammonium bromide complex with a calcium phosphate adsorbent (hydroxylapatite) in a phosphate buffer, and may be practiced either as a batch process or as a column process. The purified PRP thus obtainable is immunologically active and may be used with B. pertussis antigens to form a combined vaccine which elicits anti-PRP antibody and antipercussis antibody formations in young animals. This sera with anti-PRP antibody exhibits a strong bactericidal activity. [GB2007244A]
IE2146/78A 1977-10-28 1978-10-27 Purifying polyribosyl ribitol phosphate (prp) and vaccines containing immunologically active prp IE47474B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (2)

Publication Number Publication Date
IE782146L true IE782146L (en) 1979-04-28
IE47474B1 IE47474B1 (en) 1984-03-21

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2146/78A IE47474B1 (en) 1977-10-28 1978-10-27 Purifying polyribosyl ribitol phosphate (prp) and vaccines containing immunologically active prp

Country Status (25)

Country Link
JP (1) JPS5480408A (en)
AR (1) AR218932A1 (en)
AU (1) AU520902B2 (en)
BE (1) BE871586A (en)
CA (1) CA1117866A (en)
CH (1) CH649781A5 (en)
DD (1) DD140701A5 (en)
DE (1) DE2845745A1 (en)
DK (1) DK154327C (en)
ES (1) ES474611A1 (en)
FI (1) FI63674C (en)
FR (1) FR2407000B1 (en)
GB (1) GB2007244B (en)
GR (1) GR73991B (en)
HU (1) HU178166B (en)
IE (1) IE47474B1 (en)
IL (1) IL55433A (en)
IT (1) IT1107570B (en)
NL (1) NL7810753A (en)
NO (1) NO149611C (en)
NZ (1) NZ188211A (en)
PH (1) PH15882A (en)
PL (1) PL210545A1 (en)
SE (1) SE430753B (en)
YU (1) YU250878A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (en) * 1981-08-14 1982-02-15 Smith Kline Rit PROCESS FOR THE PREPARATION OF PURIFIED ANTIGENIC CAPSULAR BACTERIAL POLYSACCHARIDES, PRODUCTS OBTAINED AND THEIR USE
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
EP0471177B1 (en) * 1990-08-13 1995-10-04 American Cyanamid Company Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
WO1993004183A1 (en) * 1991-08-16 1993-03-04 Merck & Co., Inc. Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
NO116869B (en) * 1965-01-19 1969-06-02 Merck & Co Inc
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (en) * 1969-05-20 Roussel Uclaf IMPROVEMENT OF THE PROCESS FOR THE PREPARATION OF A SOMATIC ANTIGEN ACCORDING TO DUTCH PATENT 169754 AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2461439C3 (en) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Process for the preparation of a protective antigen from Bordetella pertussis and agent containing the same
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
SE7811192L (en) 1979-04-29
ES474611A1 (en) 1980-01-16
DD140701A5 (en) 1980-03-26
NO149611C (en) 1984-05-23
JPS5480408A (en) 1979-06-27
FR2407000B1 (en) 1983-01-21
FR2407000A1 (en) 1979-05-25
IL55433A (en) 1982-09-30
DK154327C (en) 1989-04-03
NZ188211A (en) 1984-09-28
IT7851621A0 (en) 1978-10-24
FI63674C (en) 1983-08-10
GB2007244B (en) 1982-03-31
IL55433A0 (en) 1978-10-31
NL7810753A (en) 1979-05-02
GR73991B (en) 1984-06-06
NO149611B (en) 1984-02-13
DE2845745C2 (en) 1987-10-01
CA1117866A (en) 1982-02-09
DE2845745A1 (en) 1979-05-10
FI783269A (en) 1979-04-29
NO783635L (en) 1979-05-02
HU178166B (en) 1982-03-28
CH649781A5 (en) 1985-06-14
DK479578A (en) 1979-04-29
BE871586A (en) 1979-04-27
SE430753B (en) 1983-12-12
GB2007244A (en) 1979-05-16
PH15882A (en) 1983-04-13
AU520902B2 (en) 1982-03-04
JPS6231694B2 (en) 1987-07-09
IE47474B1 (en) 1984-03-21
IT1107570B (en) 1985-11-25
YU250878A (en) 1983-12-31
AU4108178A (en) 1980-05-01
FI63674B (en) 1983-04-29
AR218932A1 (en) 1980-07-15
DK154327B (en) 1988-11-07
PL210545A1 (en) 1980-02-25

Similar Documents

Publication Publication Date Title
ATE87003T1 (en) OLIGOSACCHARIDES, IMMUNOGENS AND VACCINES AND METHODS OF MANUFACTURE OF SUCH OLIGOSACCHARIDES, IMMUNOGENS AND VACCINES.
SE8305535D0 (en) PHARMACEUTICAL PREPARATION WITH ANTINICOTIC EFFECTS AND PROCEDURES FOR PREPARING THEREOF
LU91610I2 (en) Protein D and its pharmaceutically acceptable derivatives (SYNFLORIX - Conjugated polysaccharide pneumococcal vaccine (adsorbed)
DE3481514D1 (en) NEW FRUCTOSYLTSANSFERASE AND METHOD FOR PRODUCING FRUCTOSYL DISACCHARIDES, AND A NEW HALOSACCHAROSE.
ES487046A1 (en) Purified bacterial proteoglycans, process for their preparation and vaccine containing them.
IE782146L (en) Immunologically active prp.
ATE119196T1 (en) METHOD FOR PRODUCING A FACTOR-VIIA ENRICHED FRACTION AND USE THEREOF AS A MEDICINAL PRODUCT.
ATE92335T1 (en) PURIFICATION OF WHOOPING COUGH ANTIGENS.
US3957582A (en) Purification of urokinase
ATE87486T1 (en) PROCESS FOR PRODUCTION OF TOXOID.
DE3787887D1 (en) Process for growing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine.
GB1492596A (en) Tetanus toxoid and process for its manufacture
IE891151L (en) A pasteurella vaccine
HK1004524A1 (en) Novel vaccine and method therefor
EP0316996A3 (en) Method for preparing textile treatment compositions
ES8401722A1 (en) Haemophilus influenzae type B and pertussis outer membrane component combined vaccine.
FR2597344B1 (en) IMPROVEMENT IN THE PROCESS OF PURIFYING PROTEIN ANTIGENS FROM BACTERIA BELONGING TO THE GENUS BORDETELLA, WITH A VIEW TO OBTAINING A CELLULAR VACCINE.
DE3777743D1 (en) METHOD FOR PRODUCING 1,4-DIAZABICYCLO (2,2,2) -OCTANES.
DE68917709D1 (en) Process for the preparation of a pertussis toxin toxoid.
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
DE3785266D1 (en) MASS PRODUCTION STRAP OF EPSILON-POLY-L-LYSINE, METHOD TO USE THIS STEM AND METHOD OF PRODUCING EPSILON-POLY-L-LYSINE.
EP0101562A3 (en) Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
DK0432841T3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing properties and process for their preparation
GB1508922A (en) Method for obtaining urokinase
DE3364803D1 (en) Method of preparing an immunogen of pasteurella multocida